Serial 99366346
Live / Allowed — First extension granted (statement of use) (as of 06 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99366346
- Mark type
- Design / logo
- Filed
- 29 Aug 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Michael Graif
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of myeloproliferative neoplasms and other hematologic diseases
- Class 042 — Scientific and technological services: Pharmaceutical research in the field of hematology and oncology
Owner
- Calytrix Bio, Inc., Wellesley, MA, US
- Calytrix Bio, Inc., Wellesley, MA, US
Prosecution history
- 07 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Oct 2026 — SOU EXTENSION 1 GRANTED
- 06 Oct 2026 — SOU EXTENSION 1 FILED
- 06 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Apr 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 21 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 21 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 21 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 21 Jan 2026 — ASSIGNED TO EXAMINER
- 20 Jan 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED